Edible plant vaccines: Applications for prophylactic and therapeutic molecular medicine

Trends in Molecular Medicine

Volumn 8, Issue 7, 2002, Pages 324-329

  Mason, Hugh S ^a   Warzecha, Heribert ^b   Mor, Tsafrir ^c   Arntzen, Charles J ^c  

^a United States Department of Agriculture Agricultural Research Service and Boyce Thompson Institute for Plant Research   (United States)

^b Lehrst F Pharmazeutische Biologie   (Germany)

^c ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EDIBLE VACCINE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOGLOBULIN G; PLANT EXTRACT; VIRUS VACCINE;

ALFALFA; BANANA; BIOENGINEERING; CHOLERA; CORRELATION ANALYSIS; ENCAPSULATION; FERMENTATION TECHNIQUE; GENE EXPRESSION REGULATION; IMMUNE RESPONSE; IMMUNOGENICITY; LEGUME; MOLECULAR STABILITY; MUCOSAL IMMUNITY; NONHUMAN; NORWALK GASTROENTERITIS VIRUS; PLANT PRODUCT; POTATO; PROPHYLAXIS; PROTEIN ENGINEERING; PROTEIN FOLDING; REVIEW; TOBACCO; TOMATO; TRANSGENE; TRANSGENIC PLANT; VIRUS PARTICLE;

ADMINISTRATION, ORAL; ANIMALS; BIOTECHNOLOGY; CLINICAL TRIALS; DIARRHEA; HEPATITIS B; HUMANS; MICE; PLANTS; PLANTS, GENETICALLY MODIFIED; RECOMBINANT PROTEINS; VACCINES;

ANIMALIA; BACTERIA (MICROORGANISMS); LYCOPERSICON ESCULENTUM; MEDICAGO SATIVA; NICOTIANA TABACUM; NORWALK VIRUS; SOLANUM TUBEROSUM;

EID: 0036305744     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(02)02360-2     Document Type: Review

References (43)

1. Preventing emerging infectious diseases: A strategy for the 21st century
2. Oral immunisation by transgenic plants
3. Expression of hepatitis B surface antigen in transgenic plants
4. Oral vaccine production in the edible tissues of transgenic plants
5. Edible vaccines: A concept comes of age
6. A review of oral vaccination with transgenic vegetables
7. The green revolution: Plants as heterologous expression vectors
8. Plant-based vaccines: Unique advantages
9. Medical molecular farming: Production of antibodies, biopharmaceuticals and edible vaccines in plants
10. Human hepatitis B vaccine from recombinant yeast
11. Production of recombinant proteins in transgenic plants: Practical considerations
12. Vaccination strategies for mucosal immune responses
13. Immunogenicity in humans of a recombinant bacterial-antigen delivered in transgenic potato
14. Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes
15. Basic process underlying Agrobacterium-mediated DNA transfer to plant cells
16. Optimizing the biolistic process for different biological applications
17. Transgene copy number can be positively or negatively associated with transgene expression
18. Transgene inactivation: Plants fight back!
19. Transgene-induced gene silencing in plants
20. High-frequency plastid transformation in tobacco by selection for a chimeric aadA gene
21. Expression of the native cholera toxin b subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts
22. Overexpression of the Bt cry2Aa2 operon in chloroplasts leads to formation of insecticidal crystals
23. Stable genetic transformation of tomato plastids and expression of a foreign protein in fruit
24. Milestones in chloroplast genetic engineering: An environmentally friendly era in biotechnology
25. Oral immunization of mice with transgenic tomato fruit expressing respiratory syncytial virus-F protein induces a systemic immune response
26. Generation of transgenic banana (Musa acuminata) plants via agrobacterium-mediated transformation
27. A plant-derived edible vaccine against hepatitis B virus
28. Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli
29. Edible vaccine protects mice against E. coli heat-labile enterotoxin (LT): Potatoes expressing a synthetic LT-B gene
30. Efficacy of a food plant based oral cholera toxin B subunit vaccine
31. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein
32. Recombinant Norwalk virus-like particles given orally to volunteers: Phase I study
33. Expression of Norwalk virus capsid protein in transgenic tobacco and protein and its oral immunogenicity in mice
34. Immunogenicity of transgenic plant-derived hepatitis B surface antigen
35. Production of hepatitis B surface antigen in transgenic plants for oral immunization
36. Oral immunization with hepatitis B surface antigen expressed in transgenic plants
37. A plant-based multicomponent vaccine protects mice from enteric diseases
38. Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1
39. Plant-derived immunocontraceptive vaccines
40. A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes
41. Autoantigens produced in plants for oral tolerance therapy of autoimmune diseases
42. Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants
43. + T-cell mediated immunity against B-cell malignancies